Bradley J. Monk, MD, FACS, FACOG, and Lyndsay J. Willmott, MD, discuss ovarian cancer in this CME/MOC activity titled "Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer." For the full presentation, downloadable Practice Aids, monograph, complete CME/MOC information, and to apply for credit, please visit us at http://bit.ly/2U8wkob. CME/MOC credit will be available until April 29, 2021.